These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1493 related items for PubMed ID: 17251797

  • 1. Erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis: acute ocular manifestations, causes, and management.
    Chang YS, Huang FC, Tseng SH, Hsu CK, Ho CL, Sheu HM.
    Cornea; 2007 Feb; 26(2):123-9. PubMed ID: 17251797
    [Abstract] [Full Text] [Related]

  • 2. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
    Morales ME, Purdue GF, Verity SM, Arnoldo BD, Blomquist PH.
    Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
    [Abstract] [Full Text] [Related]

  • 3. Risk factors for the development of ocular complications of Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Gueudry J, Roujeau JC, Binaghi M, Soubrane G, Muraine M.
    Arch Dermatol; 2009 Feb; 145(2):157-62. PubMed ID: 19221260
    [Abstract] [Full Text] [Related]

  • 4. The natural history of Stevens Johnson syndrome: patterns of chronic ocular disease and the role of systemic immunosuppressive therapy.
    De Rojas MV, Dart JK, Saw VP.
    Br J Ophthalmol; 2007 Aug; 91(8):1048-53. PubMed ID: 17314145
    [Abstract] [Full Text] [Related]

  • 5. Erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis: frozen-section diagnosis.
    Hosaka H, Ohtoshi S, Nakada T, Iijima M.
    J Dermatol; 2010 May; 37(5):407-12. PubMed ID: 20536645
    [Abstract] [Full Text] [Related]

  • 6. Relevance and consequences of erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in gynecology.
    Niemeijer IC, van Praag MC, van Gemund N.
    Arch Gynecol Obstet; 2009 Nov; 280(5):851-4. PubMed ID: 19277691
    [Abstract] [Full Text] [Related]

  • 7. Ocular manifestations and complications of Stevens-Johnson syndrome and toxic epidermal necrolysis: an Asian series.
    Yip LW, Thong BY, Lim J, Tan AW, Wong HB, Handa S, Heng WJ.
    Allergy; 2007 May; 62(5):527-31. PubMed ID: 17313402
    [Abstract] [Full Text] [Related]

  • 8. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necrolysis. A population-based study with particular reference to reactions caused by drugs among outpatients.
    Chan HL, Stern RS, Arndt KA, Langlois J, Jick SS, Jick H, Walker AM.
    Arch Dermatol; 1990 Jan; 126(1):43-7. PubMed ID: 2404462
    [Abstract] [Full Text] [Related]

  • 9. Diagnosis and treatment of Stevens-Johnson syndrome and toxic epidermal necrolysis with ocular complications.
    Sotozono C, Ueta M, Koizumi N, Inatomi T, Shirakata Y, Ikezawa Z, Hashimoto K, Kinoshita S.
    Ophthalmology; 2009 Apr; 116(4):685-90. PubMed ID: 19243825
    [Abstract] [Full Text] [Related]

  • 10. Oculocutaneous manifestations of the erythema multiforme/Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Wilkins J, Morrison L, White CR.
    Dermatol Clin; 1992 Jul; 10(3):571-82. PubMed ID: 1617814
    [Abstract] [Full Text] [Related]

  • 11. The CD40/CD40 ligand system is expressed in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis spectrum.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Feb; 154(2):319-24. PubMed ID: 16433803
    [Abstract] [Full Text] [Related]

  • 12. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis.
    Caproni M, Torchia D, Schincaglia E, Volpi W, Frezzolini A, Schena D, Marzano A, Quaglino P, De Simone C, Parodi A, Barletta E, Fabbri P.
    Br J Dermatol; 2006 Oct; 155(4):722-8. PubMed ID: 16965421
    [Abstract] [Full Text] [Related]

  • 13. Histopathological and epidemiological characteristics of patients with erythema exudativum multiforme major, Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Rzany B, Hering O, Mockenhaupt M, Schröder W, Goerttler E, Ring J, Schöpf E.
    Br J Dermatol; 1996 Jul; 135(1):6-11. PubMed ID: 8776350
    [Abstract] [Full Text] [Related]

  • 14. [Erythema multiforme vs. Stevens-Johnson syndrome and toxic epidermal necrolysis: an important diagnostic distinction].
    Rabelink NM, Brakman M, Maartense E, Bril H, Bakker-Wensveen CA, Bavinck JN.
    Ned Tijdschr Geneeskd; 2003 Oct 25; 147(43):2089-94. PubMed ID: 14619195
    [Abstract] [Full Text] [Related]

  • 15. Clinical characteristics of childhood erythema multiforme, Stevens-Johnson syndrome and toxic epidermal necrolysis in Taiwanese children.
    Lam NS, Yang YH, Wang LC, Lin YT, Chiang BL.
    J Microbiol Immunol Infect; 2004 Dec 25; 37(6):366-70. PubMed ID: 15599469
    [Abstract] [Full Text] [Related]

  • 16. Distinguishing between erythema multiforme major and Stevens-Johnson syndrome/toxic epidermal necrolysis immunopathologically.
    Iwai S, Sueki H, Watanabe H, Sasaki Y, Suzuki T, Iijima M.
    J Dermatol; 2012 Sep 25; 39(9):781-6. PubMed ID: 22458564
    [Abstract] [Full Text] [Related]

  • 17. Profile and pattern of Stevens-Johnson syndrome and toxic epidermal necrolysis in a general hospital in Singapore: treatment outcomes.
    Tan SK, Tay YK.
    Acta Derm Venereol; 2012 Jan 25; 92(1):62-6. PubMed ID: 21710108
    [Abstract] [Full Text] [Related]

  • 18. Acute renal failure and its risk factors in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Hung CC, Liu WC, Kuo MC, Lee CH, Hwang SJ, Chen HC.
    Am J Nephrol; 2009 Jan 25; 29(6):633-8. PubMed ID: 19155617
    [Abstract] [Full Text] [Related]

  • 19. [Stevens-Johnson syndrome and toxic epidermal necrolysis in a teaching hospital in Lomé, Togo: retrospective study of 89 cases].
    Saka B, Kombaté K, Mouhari-Toure A, Akakpo S, Tchangaï-Walla K, Pitché P.
    Med Trop (Mars); 2010 Jun 25; 70(3):255-8. PubMed ID: 20734593
    [Abstract] [Full Text] [Related]

  • 20. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS, Chao PF, Lin YJ, Chang CJ, Gau CS.
    J Clin Psychopharmacol; 2008 Oct 25; 28(5):509-17. PubMed ID: 18794645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 75.